The Midas Touch shatters Theranos’ dream of disruption
The Christensen Institute
APRIL 28, 2016
Early last week, reports surfaced that the Center for Medicare and Medicaid Services (CMS) had threatened to sanction Theranos Inc., an early-stage diagnostics company, by banning founder and CEO Elizabeth Holmes from participating in any laboratory business for at least two years. Later in the week, the matter took a turn for the worse when it was revealed that the company was under a federal, criminal investigation.